Spero Therapeutics Announces Exercise of $15.9 Million Option by BARDA for Tebipenem HBr Development - GlobeNewswire Get link Facebook X Pinterest Email Other Apps - February 05, 2020 Spero Therapeutics Announces Exercise of $15.9 Million Option by BARDA for Tebipenem HBr Development GlobeNewswire Get link Facebook X Pinterest Email Other Apps Comments
Comments
Post a Comment